In a startling recommendation, the European Medicines Agency is urging oncologists to favor transfusions over erythropoiesis-stimulating agents. Medscape Medical News
The safety and efficacy of sorafenib is examined in patients 70-years and older with advanced renal cell carcinoma. Journal of the National Cancer Institute
Massachusetts Sen. Edward Kennedy left the Boston hospital on Wednesday morning after tests to diagnose a malignant brain tumor, his doctors said. Reuters Health Information